Bioengineer.org: Biomarker may aid in determining treatment for cancer patients
UC medical student leads research to aid treatment of glioblastoma
Patients with glioblastomas or malignant brain tumors, face a difficult future. The disease is fatal, and only about 5 percent of patients are alive five years after their diagnosis, explains Haidn Foster, a third-year medical student at the UC College of Medicine and first author of a recent study of glioblastoma patients in the scholarly journal Neuro-Oncology Advances.
The findings were reported by Bioengineer.org, a biotechnology news service.
Foster’s study looked at health outcomes of 188 glioblastoma patients and found that individuals who tested positive for an antibody indicating Human cytomegalovirus (HCMV) exposure lived an average of 404 days after their cancer diagnosis compared to an average of 530 days for patients who were never infected by HCMV.
A life expectancy difference of four months is an important consideration for patients and their physicians. “For glioblastoma patients time is precious and treatment that would prolong life by a few weeks or months is considered a victory,” said Foster.
Related Stories
New guidelines recommend routine prostate cancer screening for men over 50
November 17, 2026
The University of Cincinnati Cancer's Taylor Goodstein was featured in a Healthline article discussing new American Cancer Society guidelines recommending prostate-specific antigen (PSA) screening every 2 years starting at age 50 for men at average risk, and annually starting at age 45 for those at higher risk, including Black men and men with a family history of prostate cancer.
UC experts head to Washington, D.C., to discuss AI applications in Parkinson’s care, research
November 16, 2026
UC researchers will discuss how AI could support Parkinson’s care and help researchers analyze clinical notes at the first-of-its-kind AI for Parkinson’s conference, organized by the American Parkinson Disease Association, Nov. 19 in Washington, D.C.
Some ketogenic diets found to cause mitochondrial stress and lead to inflammation
November 13, 2026
New University of Cincinnati Cancer Center research published Nov. 13 in the journal Science Advances found a ketogenic diet high in long-chain saturated fatty acids can increase inflammation.